Page last updated: 2024-09-03

omega-n-methylarginine and fr 139317

omega-n-methylarginine has been researched along with fr 139317 in 1 studies

Compound Research Comparison

Studies (omega-n-methylarginine)	Trials (omega-n-methylarginine)	Recent Studies (post-2010) (omega-n-methylarginine)	Studies (fr 139317)	Trials (fr 139317)	Recent Studies (post-2010) (fr 139317)
4,411	344	336	219	0	8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brandt, RR; Burnett, JC; Cannan, CR; Lerman, A	1

Other Studies

1 other study(ies) available for omega-n-methylarginine and fr 139317

Article	Year
Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation, 1995, Dec-01, Volume: 92, Issue:11 Topics: Animals; Arginine; Azepines; Coronary Vessels; Dogs; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Indoles; Nitric Oxide Synthase; omega-N-Methylarginine; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstriction; Viper Venoms	1995

Article

Year

Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.

Circulation, 1995, Dec-01, Volume: 92, Issue:11

Topics: Animals; Arginine; Azepines; Coronary Vessels; Dogs; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Indoles; Nitric Oxide Synthase; omega-N-Methylarginine; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Vasoconstriction; Viper Venoms

1995